Skip to the main content
F4808NLab brief
RYR1 p.Phe4808AsnHuman skeletal muscleLab collaboration briefUpdated August 15, 2026

Work package 001

The first task is to make F4808N measurable in human muscle.

F4808N has no direct public functional measurement. The project needs a qualified human-muscle model and a repeatable result.

No iPSC line, muscle model, or functional result exists yet.

Planned model path

This path is planned. It does not show completed work.

  1. 01Banked patient cellsAvailable
  2. 02iPSC clonesPlanned
  3. 03Corrected controlsPlanned
  4. 04Skeletal musclePlanned
  5. 05Replicated phenotypePlanned

Current work. Define the model, controls, assays, and agreements.

Planned work package
01

The biological question

What must the model resolve?

RYR1 helps skeletal muscle release calcium for contraction.

Different RYR1 variants can cause different effects.

The project does not yet know the F4808N mechanism.

A reliable phenotype can identify the next valid treatment test. A valid negative result can prevent the wrong work.

02

The work package

What must the lab build?

Each work unit must give a checkable output for the next unit.

  1. 01

    Generate the model

    Generate independent F4808N iPSC clones and corrected-isogenic controls. Release only clones that pass the agreed quality checks.

  2. 02

    Make skeletal muscle

    Differentiate independent clones into skeletal muscle. Confirm a stable muscle state and sufficient RyR1 expression.

  3. 03

    Measure the phenotype

    Measure allele-specific RNA, total RyR1 protein, resting calcium, stored calcium, stimulated calcium release, and stimulated force.

  4. 04

    Prove repeatability

    Repeat each important measurement across independent clones and test runs. Lock the methods, quality rules, and analysis before the final comparison.

03

The measurement set

The measurement set

Which outputs must connect?

Each output tests a different part of the biological question.

The planned measurements are allele-specific expression, total RyR1 abundance, baseline calcium state, calcium available for release, response after stimulation, and functional muscle output.

  1. 01RNAAllele-specific expression
  2. 02ProteinTotal RyR1 abundance
  3. 03Resting calciumBaseline calcium state
  4. 04Stored calciumCalcium available for release
  5. 05Stimulated releaseResponse after stimulation
  6. 06ForceFunctional muscle output

These are planned measurements. No biological result exists.

The value is not one attractive trace. The value is a linked data package that another laboratory can inspect and repeat.

04

The decision rule

What result is sufficient?

A usable result

  • The effect separates F4808N muscle from a matched control.
  • The effect repeats across independent clones and test runs.
  • The effect moves toward the control state after correction.
  • Another laboratory can repeat the locked test.

A reason to revise or stop

  • The effect changes with the clone, batch, or analysis method.
  • The model does not produce a valid RYR1 measurement.
  • The effect does not survive one defined optimization cycle.
  1. PassBegin mechanism-matched rescue work.
  2. ReviseChange the model or the test.
  3. StopDo not spend on a treatment branch.

This is a decision rule. It is not a forecast.

05

The data package

Why does this work need an integrated lab?

An integrated lab must keep the model, measurements, and analysis connected.

  1. 01Provenance

    Track provenance from donor material to analyzed result.

  2. 02Consistent differentiation

    Keep differentiation consistent across clones and batches.

  3. 03Linked measurements

    Link molecular, calcium, and force measurements.

  4. 04Transfer package

    Provide locked methods, raw data, analysis files, and the transfer package.

A negative result is useful when the model and test are valid.

The project can begin as one defined work package.

06

Current status

What exists now?

Available now

  • The exact variant and research question
  • Banked patient PBMCs
  • Draft control, assay, and decision rules

Needs a lab partner

  • A final model-generation plan
  • A costed work package and schedule
  • Institutional agreements and accountable scientific ownership

Does not exist yet

  • An F4808N iPSC line
  • Patient-derived skeletal muscle
  • A repeatable F4808N phenotype
  • A rescue result or treatment candidate

Project status reviewed August 13, 2026.

07

Contact

Could your lab own this first work package?

I have the F4808N variant. I coordinate this patient-led project with qualified laboratories and institutions.

I am looking for a lab that can own or coordinate model generation, muscle differentiation, assay development, and a reproducible data package.

A useful first discussion would test technical fit. It would also define the smallest credible scope, controls, ownership, schedule, and cost.

Discuss lab fitaviswerdlow@gmail.comRead the complete public project

No samples or clinical records are available through this site. Consent and institutional agreements must control each transfer of material or data.

Avi Swerdlow wearing glasses and a blue shirt.
Avi SwerdlowPatient and family coordinator